The Gene Panel Market continues to grow as targeted genomic testing becomes more widely used in precision medicine and disease assessment. According to MRFR, the market was valued at USD 3.56 billion in 2025 and is forecast to reach USD 14.03 billion by 2035.

Gene panel technologies allow multiple genes to be examined simultaneously, making them useful for complex genetic conditions and cancer-related testing. Falling sequencing costs and improvements in high-throughput technologies are helping laboratories expand their genomic testing capabilities.

Cancer risk assessment represents a major application, while pharmacogenetics and hereditary disease testing are opening additional opportunities. Diagnostic laboratories, hospitals, and clinics are becoming important users as genetic testing moves into more routine healthcare settings.

North America held 38.95% of market revenue in 2025, while Asia-Pacific is expected to experience the fastest growth during the forecast period. Increasing investment in genomics programs and molecular diagnostic infrastructure is supporting this expansion.

Future growth could come from personalized treatment planning, newborn screening, and population-level genetic testing. AI-powered variant analysis and automated clinical reporting may also help laboratories manage larger volumes of genomic information more efficiently.

Gain valuable insights through comprehensive industry analysis:

Spain Knee Replacement Market Trends

UK Ophthalmic Drugs Market Growth

GCC Optical Coherence Tomography Market Demand

South America Healthcare Cold Chain Logistics Market Volume

Italy Laboratory Chemicals Market Forecast